August 18, 2026

GLP-1 Side Effects, Week by Week: What’s Normal, What Needs a Doctor, and How to Manage Each One By Dr. Neha Shah, Bariatric & Metabolic Surgeon, Co-Founder & Clinical Lead, The Good Weight Key Takeaways GI side effects affect 40–70% of people starting GLP-1 therapy; nausea alone is reported in 40–58% of patients, mostly in the first 1–8 weeks. Nausea typically peaks in week 1 and eases as the body adapts; constipation tends to appear in weeks 2–4 and lingers longer. Each dose increase (usually around week 4–5) can temporarily bring symptoms back for 3–7 days. Up to 25–45% of weight lost on GLP-1 therapy can be lean muscle mass if protein intake and resistance training aren’t actively managed.[2] Serious but rare risks — pancreatitis, gastroparesis, gallbladder complications — need immediate medical attention, unlike routine GI adjustment symptoms.[3] GI side effects are the leading cause of GLP-1 discontinuation in real-world data, most often when dose escalation outpaces tolerance.[4] Almost every side effect conversation I have with a new Member follows the same arc: excitement about starting, a rough first fortnight, a moment of “is this normal?”, and then — for the vast majority — things settling into a manageable rhythm. GLP-1 medications are genuinely effective tools, but they are not side-effect-free, and going in with an accurate map of what to expect makes the difference between someone who sails through titration and someone who quits in week three over something entirely manageable. This is that map — organised by when symptoms actually appear, what’s expected physiology versus what’s a red flag, and exactly what to do about each one. Why GLP-1 Medications Cause Side Effects in the First Place GLP-1 receptor agonists work partly by slowing gastric emptying — the rate at which food leaves your stomach and moves into your intestine. This is precisely why they curb appetite so effectively, and it’s also precisely why the earliest, most common side effects are gastrointestinal. A 2025 review in Mayo Clinic Proceedings found that 40–70% of patients experience gastrointestinal adverse effects on GLP-1 and GLP-1/GIP therapies, with nausea, vomiting, diarrhoea, constipation, and reflux the most frequent (Mayo Clinic Proceedings, 2025)[1] — but the overwhelming majority are mild-to-moderate and temporary, easing as the body adapts to each dose. The GLP-1 Side Effect Timeline Days 1–3: The First Wave Most people notice their first symptoms within 24–72 hours of the first injection — mild nausea, reduced appetite, occasional headache or light-headedness. This is your gut registering the change in gastric emptying speed; it is expected and, for most Members, mild. What helps: Small, bland, low-fat meals (think dal-rice, khichdi, plain dosa rather than fried or rich food); eating slowly and stopping at first fullness; staying upright for 30–60 minutes after eating rather than lying down. Week 1: Nausea Peaks Nausea is typically most intense in the first week, especially on injection day and the day after. For most patients it begins to noticeably ease by the end of week one as the body starts adapting. What helps: Ginger tea or ginger candies (genuinely evidence-backed for nausea relief); five to six small meals instead of three large ones; plain, easy-to-digest foods — curd rice, khichdi, soups, bananas, boiled eggs. Weeks 2–4: Constipation or Loose Stools Emerge As nausea starts easing, a second wave often appears — constipation in some people, loose stools in others, depending on individual gut response and which molecule you’re on. Constipation is reported in roughly 12–25% of GLP-1 users depending on the drug, and unlike nausea, it tends to linger longer, often persisting through weeks two to four before substantially improving. What helps: Build fibre up gradually rather than all at once (a sudden high-fibre load can worsen bloating); 2.5–3 litres of water daily; a 20–30 minute daily walk, which genuinely helps gut motility; if constipation persists, ask your doctor about a stepwise approach starting with an osmotic option rather than jumping straight to stimulant laxatives. Weeks 4–6: The Dose-Increase Flare Every GLP-1 protocol increases the dose in steps, typically around week four or five for the first escalation. Each increase can temporarily bring back nausea or GI symptoms for roughly 3–7 days before the body adapts again. This is one of the most important things I tell Members: if side effects from your current dose haven’t settled, don’t escalate yet. The titration schedule is a guide, not a race — your doctor can hold you at a dose longer if you need it. Months 2–3: Fatigue and “Food Noise” Changes As calorie intake drops meaningfully, some Members notice fatigue, mild dizziness on standing, or a change in mood as appetite and “food noise” quiet down. This is usually a sign of simply eating too little, not a drug side effect requiring dose changes. What helps: Deliberately structured, protein-forward meals even when you don’t feel hungry; adequate salt and fluid intake, especially in Chennai and Bengaluru’s heat; a check on your blood pressure medication doses if you’re on them, since appetite and weight changes can mean your existing dosages need revisiting. Months 3–6+: The Muscle Loss Window This is the side effect that gets the least airtime and matters the most long-term. A 2024 review in Circulation found that lean mass can account for up to 25–45% of total weight lost on semaglutide and tirzepatide in registration trials, depending on the medication and body composition method used (Neeland et al., Circulation, 2024)[2] — particularly when protein intake and resistance training aren’t actively managed. What helps: Protein intake above 1.2 g per kg of body weight daily, spread evenly across meals; two to three resistance training sessions a week (even bodyweight or band-based training counts); periodic body composition (BCA) scans to track fat loss versus muscle loss, not just the number on the scale. The Complete Symptom & Action Grid Symptom Typical Timing Action Mild nausea, reduced appetite Days 1–7, each dose increase Manage at home — small meals, ginger, low-fat food Constipation Weeks 2–6 Fibre, fluids, movement; escalate to

The Real Cost of GLP-1 Therapy in India: A Doctor’s Complete 2026 Price Guide By Dr. Neha Shah, Bariatric & Metabolic Surgeon, Co-Founder & Clinical Lead, The Good Weight Key Takeaways Generic semaglutide in India costs from ₹1,290/month at the starting dose, rising to ₹1,300–4,200/month at maintenance doses. Branded Ozempic and Wegovy cost from ~₹5,660/month after Novo Nordisk’s April 2026 price cuts (up to 48% off Wegovy, 36% off Ozempic). Mounjaro (tirzepatide) is the most expensive option, running ₹13,125–27,500/month depending on dose, since it remains under patent with no generic yet. Semaglutide’s Indian patent expired on 20 March 2026, triggering 40+ DCGI-approved generic brands. Total monthly cost should also include labs, physician consults, and nutrition support — not just the medicine strip price. No IRDAI-regulated insurance in India currently covers GLP-1 medication for the obesity indication. Almost every Member who walks into our Chennai or Bengaluru centres asking about GLP-1 therapy starts with the same question, and it isn’t about side effects or efficacy. It’s: “Doctor, how much is this actually going to cost me every month?” It’s a fair question, and in 2026 the honest answer is “it depends enormously on which molecule, which brand, and which pathway you choose” — because this market has changed more in the last twelve months than in the previous five years combined. Two events reshaped GLP-1 pricing in India this year: semaglutide’s Indian patent expired on 20 March 2026, opening the door to 40+ generic brands, and Novo Nordisk responded on 1 April 2026 by cutting its own Ozempic and Wegovy prices by up to 36–48%. As a clinician who prescribes and titrates these medications daily, I want to walk you through exactly what you’ll pay — medicine, consults, labs, and the costs nobody mentions on Instagram — so you can budget for this properly before you start. Quick Answer: What Does GLP-1 Therapy Cost in India in 2026? Medication Molecule Monthly Cost (Starting Dose) Monthly Cost (Maintenance Dose) Generic Semaglutide (vials) Semaglutide ₹1,290–1,300 ₹1,300–4,200 Generic Semaglutide (pens) Semaglutide ₹1,800–4,500 ₹4,000–6,000 Ozempic (branded) Semaglutide ~₹5,660 ~₹9,000 (1 mg) Wegovy (branded) Semaglutide ~₹5,660 ~₹16,400 (2.4 mg) Mounjaro (branded) Tirzepatide ₹13,125–14,000 (2.5 mg) ₹22,000–27,500 (10–15 mg) Prices are typical Indian retail MRP as of mid-2026 and vary by city, pharmacy chain and exact dose. Always confirm current pricing with your prescribing doctor or pharmacy at the time of purchase. Why Prices Just Fell: The Two Events That Changed Everything 1. The Semaglutide Patent Expired (20 March 2026) Semaglutide — the molecule in Ozempic and Wegovy — lost patent protection in India this March. Within weeks, more than 40 DCGI-approved generic brands entered the market from major Indian manufacturers including Natco, Sun Pharma, Dr. Reddy’s, Cipla, Zydus, Alkem and Glenmark. Vial-based generics now start from as little as ₹1,290 a month, and pen-format generics from roughly ₹1,800–4,500. 2. Novo Nordisk Cut Its Own Prices (1 April 2026) Facing genuine price competition for the first time, Novo Nordisk cut Ozempic prices by up to 36% and Wegovy prices by up to 48%. The starting 0.25 mg dose of both now costs roughly ₹5,660 a month — a fraction of what it did in late 2025. 3. Tirzepatide (Mounjaro) Remains Untouched Tirzepatide is still under patent in India, with generics not expected before 2027–28. As the only dual GIP/GLP-1 agonist available here, and India’s top-selling drug by value since October 2025, its pricing hasn’t moved — it remains the most expensive option on the table, running from roughly ₹13,000 at the starting dose to ₹25,000–27,500 at higher maintenance doses. Branded vs Generic: What Are You Actually Paying For? This is the question I get asked most, and I want to be clinically precise about it rather than diplomatic. Generic semaglutide contains the same active molecule as Ozempic and Wegovy. What you’re paying extra for with the branded pen is: Manufacturing and quality assurance track record from an internationally audited facility. Device engineering — branded auto-injector pens are generally easier to dose accurately than drawing from a vial with a syringe. A longer real-world safety and outcomes dataset, including cardiovascular and kidney outcome trials that some generics haven’t yet replicated in India. What matters clinically is that whichever option you choose, it should be a DCGI-approved brand, sourced from a licensed pharmacy, and prescribed and titrated by a doctor — never self-purchased or self-dosed. At The Good Weight, our clinical team reviews the manufacturer, batch quality, and cold-chain handling before we recommend any specific brand to a Member, because with an injectable prescription drug, the ₹1,000 you save by cutting corners on sourcing is not worth the risk. The Hidden Costs Nobody Mentions The medicine strip price is only part of the real monthly outlay. Here’s what a properly run GLP-1 programme should also budget for: Baseline and follow-up labs — thyroid panel, HbA1c/fasting glucose, kidney and liver function, lipid profile. Typically ₹2,000–4,000 at baseline, repeated every 3–6 months. Physician consultation and titration support — dose changes should be doctor-guided, not self-managed off a YouTube video. Budget ₹1,000–2,500 per review consult, or a bundled monthly programme fee. Body composition monitoring — a BCA (body composition analysis) scan tracks how much of your weight loss is fat versus muscle, which matters enormously on GLP-1 (see our companion article on muscle loss). Most clinics offer this at ₹500–1,500 per scan. Protein and nutrition support — appetite suppression makes it genuinely hard to hit protein targets through food alone; many Members add a protein supplement or a structured food kit, typically ₹1,500–2,500/month. Cold-chain storage — GLP-1 pens need 2–8°C refrigeration; factor this into travel and storage planning, especially in Chennai’s climate. Six-Month Cost Reality Check: What You’ll Actually Spend Because these medications are titrated — you start low and increase the dose gradually over several months — your early months cost meaningfully less than your maintenance months. A rough six-month picture for generic semaglutide, including consults and labs, typically lands between ₹25,000 and ₹45,000 total; branded Wegovy or Ozempic across